Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02125396
What this trial is testing

Adjuvant Radiotherapy Comparing TACE for Curative HCC

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 150
Large-scale testing (Phase 3)Ended earlyNCT02200042
What this trial is testing

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

Who this might be right for
Stage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma
NRG Oncology 1
Not applicableStudy completedNCT04145141
What this trial is testing

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver CancerCholangiocarcinoma
National Cancer Institute (NCI) 132
Not applicableStudy completedNCT06031129
What this trial is testing

Butorphanol in Pain Following Ablation for Hepatic Tumor

Who this might be right for
Visceral PainMicrowave AblationHepatic Tumor
Bibo Wang 300
Testing effectiveness (Phase 2)Ended earlyNCT00427973
What this trial is testing

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT05864105
What this trial is testing

PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Biotheus Inc. 35
Post-approval studies (Phase 4)UnknownNCT01768195
What this trial is testing

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Who this might be right for
Hepatitis B
Peking University 80
Large-scale testing (Phase 3)UnknownNCT01655641
What this trial is testing

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

Who this might be right for
Gastric CancerPancreatic CancerHepatocellular Cancer+1 more
Tribhuvan University Teaching Hospital, Institute Of Medicine. 118
Large-scale testing (Phase 3)UnknownNCT02646137
What this trial is testing

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Sherief Abd-Elsalam 50
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)UnknownNCT02767375
What this trial is testing

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 192
Not applicableLooking for participantsNCT04657042
What this trial is testing

4D-MRI for Precision Medicine

Who this might be right for
Healthy VolunteersLiver CancerLung Cancer
University of Virginia 100
Early research (Phase 1)Study completedNCT00960557
What this trial is testing

Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden

Who this might be right for
Neoplasm Metastasis
Mateon Therapeutics 16
Not applicableStudy completedNCT04627012
What this trial is testing

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAnti-PD1 AntibodyLiver Diseases
Sun Yat-sen University 600
Early research (Phase 1)Study completedNCT03993327
What this trial is testing

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal Carcinoma Metastatic in the LiverMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+3 more
City of Hope Medical Center 4
Not applicableUnknownNCT05205629
What this trial is testing

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaDonafenib
Shanghai Zhongshan Hospital 150
Not applicableStudy completedNCT03813953
What this trial is testing

The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver Resection

Who this might be right for
Liver Cancer
University of Edinburgh 160
Not applicableStudy completedNCT02722395
What this trial is testing

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Primary Liver CancerMetastatic Liver Cancer From Any Cancer Site
Duke University 5
Early research (Phase 1)Study completedNCT00005077
What this trial is testing

Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
Not applicableWithdrawnNCT03452553
What this trial is testing

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Who this might be right for
Hepatocellular Carcinoma (HCC)
Boston Scientific Corporation
Next Page